Back to User profile » Dr Dian Pitaloka
Papers published by Dr Dian Pitaloka:
Gingerols and Shogaols of Zingiber officinale var. sunti Valeton as Potential Allosteric Agonists of Human GABAA Receptor by in silico Pharmacology Approach
Kuswandani F, Wilar G, Wahyuni IS, Megantara S, Pitaloka DAE, Levita J, Jiranusornkul S
Journal of Experimental Pharmacology 2025, 17:359-374
Published Date: 17 June 2025
Phytochemical Analysis, Computational Study, and in vitro Assay of Etlingera elatior Inflorescence Extract Towards Inducible Nitric Oxide Synthase
Prayoga DK, Pitaloka DAE, Aulifa DL, Budiman A, Levita J, Jiranusornkul S, Nguyen BP
Journal of Experimental Pharmacology 2025, 17:123-141
Published Date: 8 March 2025
Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
Pitaloka DAE, Syaputri Y, Nurlilasari P, Khairunnisa SF, Saallah S
Drug Design, Development and Therapy 2024, 18:1969-1979
Published Date: 31 May 2024
Development and Validation of Questionnaire to Measure Parents’ Knowledge, Attitude, and Practice on Self-Medication of Children with Antibiotics in Bandung, Indonesia
Pitaloka DAE, Yuda Kusuma I, Insyirah A, Oktariani AN, Pratiwi H, Majida Alfarafisa N
Infection and Drug Resistance 2023, 16:6111-6120
Published Date: 12 September 2023
Role of Pharmacists in Antimicrobial Stewardship During COVID-19 Outbreak: A Scoping Review
Kusuma IY, Pratiwi H, Pitaloka DAE
Journal of Multidisciplinary Healthcare 2022, 15:2605-2614
Published Date: 9 November 2022
Herbal Therapy for the Treatment of Seborrhea Dermatitis
Mustarichie R, Rostinawati T, Pitaloka DAE, Saptarini NM, Iskandar Y
Clinical, Cosmetic and Investigational Dermatology 2022, 15:2391-2405
Published Date: 7 November 2022
Multi Epitope-Based Vaccine Design for Protection Against Mycobacterium tuberculosis and SARS-CoV-2 Coinfection
Pitaloka DAE, Izzati A, Amirah SR, Syakuran LA
Advances and Applications in Bioinformatics and Chemistry 2022, 15:43-57
Published Date: 2 August 2022
Omics Biomarkers for Monitoring Tuberculosis Treatment: A Mini-Review of Recent Insights and Future Approaches
Pitaloka DAE, Syamsunarno MRAA, Abdulah R, Chaidir L
Infection and Drug Resistance 2022, 15:2703-2711
Published Date: 28 May 2022
COVID-19 Pandemic Disruption on the Management of Tuberculosis Treatment in Indonesia
Caren GJ, Iskandar D, Pitaloka DAE, Abdulah R, Suwantika AA
Journal of Multidisciplinary Healthcare 2022, 15:175-183
Published Date: 26 January 2022
A Narrative Review of Statin-Induced Rhabdomyolysis: Molecular Mechanism, Risk Factors, and Management
Safitri N, Alaina MF, Pitaloka DAE, Abdulah R
Drug, Healthcare and Patient Safety 2021, 13:211-219
Published Date: 8 November 2021
